Input from various signaling pathways in conjunction with specific transcription factors (TFs), noncoding RNAs, and epigenetic modifiers governs the maintenance of cellular identity. Endogenous or exogenous TFs operate within certain boundaries, which are set, in part, by the cell type-specific epigenetic landscape. Ectopic expression of selected TFs can override the cellular identity and induce reprogramming to alternative fates. In this minireview, we summarize many of the classic examples and a large number of recent studies that have taken advantage of TF-mediated reprogramming to produce cell types of biomedical relevance.For many years, it was unclear whether differentiation involves irreversible changes to the genome that would restrict a cell's developmental potential. Early work by Briggs and King (1) and later Gurdon (2) addressed this subject using somatic cell nuclear transfer (SCNT) 2 from various donor nuclei into enucleated frog oocytes. Successful generation of viable organisms by SCNT demonstrated that the genome of a differentiated cell does retain all genetic information necessary for normal development. Later experiments were able to expand these seminal findings to mammals (3). SCNT using donor nuclei from genetically marked lymphoid cells (4) and olfactory receptor neurons (5) demonstrated further that even terminally differentiated and post-mitotic genomes could be reprogrammed. More recently, human somatic cell nuclei were also shown to be amenable to reprogramming by SCNT. However, in contrast to other species, this could be achieved only without prior removal of the oocyte nucleus (6).Other cell types besides oocytes have been shown to possess factors capable of activating silenced loci in a somatic genome. For instance, introduction of a chicken erythrocyte nucleus into the cytoplasm of a HeLa cell results in chromatin decondensation and initiation of RNA synthesis from the previously inactive erythrocyte genome (7). Later studies in mice and humans demonstrated that fusion of somatic cells with embryonic stem cells (ESCs) or embryonic germ cells reactivates pluripotencyrelated genes from the somatic genome and creates pluripotent, albeit tetraploid (4N), cells (8 -10). Although these have limited clinical value, their genesis has provided a useful experimental platform for studying cellular plasticity and reprogramming (11). Moreover, the fusion experiments offered evidence that ESCs, like oocytes, zygotes, and early blastomeres, contain factors that are sufficient to reprogram a somatic cell.Initial evidence for the capacity of selected transcription factors (TFs) to direct cellular reprogramming came from the classic myoD experiments and subsequent lineage conversions in the hematopoietic system (reviewed in Ref. 12). However, a major advancement in the field occurred in 2006 with the landmark study by Takahashi and Yamanaka (13), who reported the generation of induced pluripotent stem cells (iPSCs) through ectopic expression of only four TFs.
Converting Cell StatesIn contrast to ...